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INTRODUCTION
Urinary tract infections (UTI) are common among females, 
accounting for upward of 10.5 million visits to physician 
offices and emergency departments (ED) per year.1 While 
it is important to promptly treat UTIs with antibiotics to 
prevent complications such as septic shock and renal scarring 
in children,2,3 it is also prudent to use antibiotics only when 
needed in an effort to reduce adverse medication effects and 
antibiotic resistance. With common UTI pathogens, resistance 
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Introduction: Urinary tract infections (UTI) are a common indication for antibiotic use in the emergency 
department (ED). With antibiotic resistance on the rise, it is essential that antibiotics be prescribed 
appropriately for UTIs. Our objective was to evaluate the appropriateness of antibiotic prescriptions by 
ED providers for uncomplicated cystitis and pyelonephritis.
Methods: We conducted a retrospective study of females ages 2-50 years seen in an academic ED 
from January 2017 to April 2018 diagnosed with UTI. We assessed the appropriateness of discharge 
antibiotic prescriptions, as determined by adherence to clinical practice guidelines, best evidence for 
the particular indication (cystitis vs pyelonephritis for children and adults), and the local antibiogram.
Results: A total of 421 patients were included in this study. Of these, 60 children and 198 adults were 
diagnosed with cystitis, and 47 children and 116 adults were diagnosed with pyelonephritis. Treatment 
in the absence of true infection was common, with culture-confirmed UTI occurring in only 17/50 (34%) 
of children and 60/129 (47%) of adults diagnosed with cystitis, and 23/40 (58%) of children and 58/87 
(67%) of adults diagnosed with pyelonephritis, among patients who had urine cultures. The type of 
antibiotic prescribed was appropriate in 53/60 (88%) of children and 135/198 (68%) of adults with 
cystitis, and 38/47 (81%) of children and 53/116 (46%) of adults with pyelonephritis. The most common 
inappropriate antibiotic types were beta-lactams in adults (n = 92), nitrofurantoin for pyelonephritis (n 
= 16), and amoxicillin (n = 15). Dosing and duration errors were also common, occurring in 122/279 
(44%) of prescriptions of an appropriate antibiotic type. The frequency of errors in the type of antibiotic 
prescribed was similar among provider types (attending physician, resident physician, and advanced 
practice clinician; p = 0.926).
Conclusion: This study reveals room for improvement in antibiotic prescription practices across 
provider cohorts in the ED for the management of uncomplicated cystitis and pyelonephritis in females. 
[West J Emerg Med. 2020;21(3)633-639.]
to fluoroquinolones and trimethoprim-sulfamethoxazole 
(TMP-SMX) has been on the rise. Additionally, there has been 
increasing prevalence of extended-spectrum β-lactamase and 
other multi-drug resistant organisms.4-6
Given the implications of inappropriate antibiotic 
prescription practices to individuals and populations, it is 
essential that providers appropriately select antibiotic treatment 
for the management of suspected UTIs. Guidelines from sources 
such as the Infectious Diseases Society of America (IDSA) 
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Population Health Research Capsule
What do we already know about this issue?
Previous studies have found overuse of 
antibiotics for urinary tract infections (UTI).
What was the research question?
To evaluate the appropriateness of antibiotic 
prescriptions for UTIs.
What was the major finding of the study?
Antibiotics were overused and inappropriate 
antibiotics were commonly prescribed for 
suspected UTIs.
How does this improve population health?
This study identified antibiotic misuse 
including overly broad antibiotics and 
overdiagnosis of UTIs, which can promote 
antimicrobial resistance.
and the American Academy of Pediatrics (AAP) can provide 
guidance.7,8 However, local factors, such as site-specific antibiotic 
resistance, also must be taken into account. Most organizations 
now publish hospital-wide antibiograms, which were present 
in 98% of United States hospitals in 2014.9 Although hospital 
antibiograms exist, it remains unknown whether providers are 
using this tool, in conjunction with guidelines, such as those 
from the IDSA, to tailor their prescription practices to their 
particular location. In a recent survey of pediatric providers, 70% 
reported access to local antibiograms and, of these, only 50% 
reported using the antibiogram “always” or “most of the time” 
when empirically prescribing antibiotics for UTIs.10 Prescribing 
practices for UTIs are variable and problems exist, including the 
use of overly broad antibiotics and treatment in the absence of 
true infection.11,12
To investigate antibiotic prescribing practices for suspected 
UTIs, we primarily sought to determine whether empiric 
antibiotic selection was appropriate for suspected UTIs in 
children and adults. Secondarily, we set out to analyze frequency 
of antibiotic prescription in the absence of true infection and 
whether variation in appropriate antibiotic selection existed 
between specific provider groups, including attending physicians, 
resident physicians, physician assistants, and nurse practitioners. 
We hypothesized that inappropriate antibiotics were frequently 
prescribed, that patients were frequently treated with antibiotics in 
the absence of true infection, and that variation existed between 
provider groups.
METHODS
Study Design 
The study was a retrospective analysis of females ages 
2 to 50 years diagnosed with a UTI who were treated and 
discharged between January 1, 2017 – April 16, 2018, from an 
academic medical center ED. Females age 18 years or older were 
categorized as adults, while females under the age of 18 years 
were categorized as children. Institutional review board approval 
was obtained. We identified patients via an ED diagnosis of 
one or more of the following International Classification of 
Diseases (ICD-10) codes for UTI: ICD-10 CM: N39.0 (UTI, 
site not specified); N30.00 (acute cystitis without hematuria); 
N30.91 (cystitis, unspecified with hematuria); N30.80 (other 
cystitis without hematuria); N30.0 (acute cystitis); N30.01 
(acute cystitis with hematuria); N30.90 (cystitis, unspecified 
without hematuria); N30 (cystitis); N30.8 (other cystitis); N30.9 
(cystitis, unspecified); N30.81 (other cystitis with hematuria); 
N10 (acute pyelonephritis); and N12 (pyelonephritis). All data 
collection was conducted by PC after receiving training from 
KK. Approximately 5% of charts were reviewed by both authors 
independently to assess for congruency, including random charts 
and any cases in which there was uncertainty. 
We excluded patients from this study if they had UTI 
complications (including renal abscess, septic shock, 
concurrent nephrolithiasis, or required hospital admission 
or observation); had pre-existing renal or urologic disease 
(including vesicoureteral reflux or other functional abnormality; 
obstructive uropathy, permanent or intermittent catheter, 
history of urinary tract surgery); were pregnant or up to six-
weeks post-partum; were prisoners; had diabetes mellitus; 
or were immunocompromised. This included patients taking 
medications such as steroids, biologics, and chemotherapeutic 
drugs. We also excluded patients with recurrent UTI (had a UTI 
with or without antibiotic treatment within the prior month) 
and patients who were already prescribed an antibiotic for the 
current UTI prior to the ED visit.
 Patients were categorized as having uncomplicated 
cystitis or pyelonephritis based on their ICD-10 code. In cases 
where the ICD-10 code CM N39.0 for “urinary tract infection, 
site not specified” was used, the authors categorized patients 
as having either cystitis or pyelonephritis based on medical 
chart documentation of symptoms, vital signs, physical 
exam, and provider impression. Patients were assigned to 
the pyelonephritis cohort if they had fever, flank pain, or 
costovertebral angle tenderness.13 
Outcomes and Data Analysis
The primary outcome was the appropriateness of the 
antibiotic prescription for UTI, including the antibiotic type, 
dose, and duration. We determined a list of appropriate discharge 
antibiotics (Table 1, Appendix Tables 1 and 2) using guidelines 
from the IDSA, the AAP, UpToDate, and our hospital’s 2016 
outpatient antibiogram (Appendix Figure 1).7,8,13-15 These 
references were selected as they represent current and reputable 
sources used by providers in our ED. For children, there are many 
potential antibiotic options with limited evidence for superiority 
of a particular antibiotic or regimen.16 Thus, any antibioitcs 
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recommended by expert sources7,14,15 with favorable susceptibility 
at our institution (> 80% of E. coli isolates susceptible) were 
included. For adults, antibiotics recommended by IDSA 
guidelines were used.8  Based on our local susceptibilities 
(Appendix Figure 1), all of the antibiotic options had favorable 
resistance patterns to E. coli (more than 80% of isolates 
susceptible) and were included as appropriate. 
We did not include beta-lactams as appropriate options 
for adults in accordance with the IDSA guidelines, which 
recommend against routine use for UTI due to inferior efficacy, 
as there are numerous other antibiotic options for adults with 
favorable local susceptibilities. Allergies were reviewed during 
chart review, and no patients were allergic to all appropriate 
first-line options. There are no standardardized antibiotic 
recommendations in place in our ED. Our hospital antibiogram is 
available on the hospital infonet, and pocket cards are distributed 
periodically. It provides susceptibilities for various organisms for 
inpatients and outpatients, but does not provide empiric treatment 
recommendations for infection types, such as UTI.  
The secondary outcomes were the frequency of positive 
urine culture (when obtained) and the appropriateness of 
discharge antibiotic prescriptions between provider types 
(resident physician, advanced practice clinician, and attending 
physician). UTI was defined as growth of greater than or equal 
to 100,000 colonies of a single uropathogen via clean catch, 
growth of greater than or equal to 50,000 colonies of a single 
uropathogen via direct catheterization, or growth of greater than 
or equal to 50,000 colonies of a single uropathogen via clean 
catch in the presence of a positive urinalysis.13,14 We performed 
data analysis using descriptive statistics and chi-squared tests 
where applicable.
RESULTS 
During the study period, 421 patients met inclusion 
criteria (Figure 1). Common reasons for exclusion in adults 
included diabetes mellitus, presence of nephrolithiasis, and 
current treatment with antibiotics or immunosuppressing 
medications. Common reasons for exclusion in children included 
vesicoureteral reflux and current antibiotic treatment. Of the total 
421 patients, 258 (61.3%) were classified as having cystitis and 
163 were classified as having pyelonephritis (38.7%) (Figure 1). 
The median age for children was nine years and the median age 
for adults was 27 years.
Urine cultures were performed in 73% of patients 
(306/421), with higher utilization of urine culture in patients 
with pyelonephritis (127/163, 78%) than in patients with cystitis 
(179/258, 69%) (Figure 1). The presence of UTI was not 
confirmed for a substantial proportion of patients diagnosed with 
cystitis, whereas more patients diagnosed with pyelonephritis 
had a culture-proven UTI (Figure 1). A vast majority of the true 
positive urine cultures grew E. coli (80%).
The appropriateness of discharge antibiotic prescriptions 
(Appendix Figure 2) is shown in Table 2. The majority of patients 
received an appropriate antibiotic type, except for adults with 
pyelonephritis (46%). Figures 2 and 3 detail the reasons for 
lack of accordance with clinical guidelines for antibiotic type in 
children and adults, respectively. Errors in dosing and duration 
were common, with only 157 (56%) of those with appropriate 
antibiotic type having correct dosing and duration when 
compared to our established criteria (Appendix Tables 1 and 2). 
Duration was more frequently incorrect than dosing. Antibiotics 
were commonly prescribed for a longer, rather than shorter, 
duration than is specified in the Appendix Tables 1 and 2. Of the 
104 patients with incorrect duration, 73 patients (70%) received 
antibiotics for a longer duration and 31 patients (30%) received 
antibiotics for a shorter duration.
A total of 130 unique prescribers treated the 421 patients 
included in the study. We assessed the frequency of appropriate 
discharge medication prescription type, independent of dosage 
and duration, for cystitis and pyelonephritis combined across 
the following three cohorts: attending physician (18/27, 67%); 
resident physician (168/249, 67%); and advanced practice 
clinician (93/145, 64%).  No difference was found between the 
groups (p = 0.926). 
Age group Infection type Appropriate medications
Children14,15 Uncomplicated cystitis Amoxicillin / clavulanic acid (immediate release formulations)
1st-3rd generation cephalosporin
Nitrofurantoin 
Trimethoprim-sulfamethoxazole
Pyelonephritis Amoxicillin / clavulanic acid (immediate release formulations)
1st-3rd generation cephalosporin
Trimethoprim-sulfamethoxazole
Adults8,13 Uncomplicated cystitis Fosfomycin
Nitrofurantoin
Trimethoprim-sulfamethoxazole
Pyelonephritis Ciprofloxacin
Levofloxacin
Trimethoprim-sulfamethoxazole
Table 1. List of appropriate antibiotic types for the management of uncomplicated cystitis and pyelonephritis.
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DISCUSSION
In this study we found a number of areas for improvement 
in the initial management of female UTIs in an academic 
ED. Furthermore, we demonstrated that opportunity for 
improvement exists across all provider cohorts studied. These 
findings can guide improvement efforts for judicious use of 
antibiotics. Overtreatment of UTI was common, in particular 
for cystitis. As many as two-thirds of children who were treated 
for cystitis had a negative urine culture. Strategies to improve 
diagnostic accuracy and/or decrease unnecessary antibiotic 
treatment include the use of a decision aid, such as that by 
McIsaac et al for females with suspected cystitis.17 This simple 
decision aid using three variables (dysuria, leukocytes greater 
than a trace amount, and positive nitrites) was statistically 
associated with a positive urine culture result. 
Strategies to reduce antibiotic overuse include delaying 
antibiotic prescription if infection is uncertain and discontinuing 
antibiotics if the urine culture results as negative. In a study by 
Knottnerus et al, many women were willing to delay antibiotic 
initiation for cystitis while awaiting urine culture result. More 
than half of these women experienced resolution of symptoms 
within a week without antibiotic therapy.18 In the pediatric and 
adult settings, nurse, clinician, and pharmacist follow-up after 
urine culture result has led to decreased total antibiotic days.19,20 A 
common theme is the need for improved, ED-based antimicrobial 
stewardship strategies, as the ED is unique and may require its 
own specific interventions. 21 
Overtreatment of UTIs was also found in the form of 
excessive antibiotic duration (Table 2), particularly for cystitis. 
The variation in length of antibiotic courses could be due in 
part to limited evidence for superiority of particular regimens, 
especially for children.16,22 However, longer than recommended 
antibiotic courses can contribute to antibiotic resistance.23 
Potential strategies for improving dosing and duration include 
interventions to the electronic health record, which have been 
demonstrated to improve appropriate antibiotic delivery.24,25  
Finally, we investigated the utilization of appropriate 
antibiotic types given the local antibiogram and evidence-
based guidelines. Adherence to the IDSA recommendations 
can increase narrow spectrum antibiotic use and decrease 
unnecessary antibiotic days.26,27 In our study, we found overuse 
of fluoroquinolones for cystitis (albeit at lower rates than in 
other reported studies).26,27 This antibiotic class can cause 
serious advserse events, promote antibiotic resistance, and 
predispose to Clostridum difficile infections.28-31 Other deviations 
from the guidelines included the use of potentially ineffective 
antimicrobials, such as amoxicillin and nitrofurantoin for 
pyelonephritis. While clinical outcomes were not tracked, the 
liklihood of treatment failure is high with these agents, with E. 
coli resistance to amoxicillin being widespread.8 
The most common deviation from IDSA guidelines in adults 
was treatment with beta-lactams (Figure 3). The significance 
of this is unclear despite how common this practice is at our 
institution. These antibiotics are likely prescribed because 
957 patients were 
assessed for eligibility
536 excluded
421 patients included
107 pediatric females 314 adult females
60 with 
uncomplicated 
cystitis
198 with 
uncomplicated 
cystitis
47 with 
pyelonephritis
116 with 
pyelonephritis
50 with urine 
culture
87 with urine 
culture
129 with urine 
culture
40 with urine 
culture
17 (34%) urine 
culture positive
23 (58%) urine 
culture positive
60 (47%) urine 
culture positive
58 (67%) urine 
culture positive
Figure 1. Flow diagram of study participants diagnosed with urinary tract infections.
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local susceptibilities are favorable for 1st- and 2nd-generation 
cephalosporins. Furthermore, additional studies have been 
published since the IDSA guidelines in 2011 supporting efficacy 
of beta-lactams for the treatment of UTIs in adults.32-35 The use of 
beta-lactams could be studied further to provide more potential 
treatment options, especially given that antibiotic resistance to 
many other antibiotic classes is on the rise.  
LIMITATIONS
This study analyzed adherence to clinical guidelines 
and expert recommendations, assuming that these promote 
optimal care. Additional limitations of this study are associated 
with its retrospective design. The determination of antibiotic 
appropriateness relied on diagnosis of either cystitis or 
pyelonephritis; however, some patients had a non-specific 
diagnosis of “urinary tract infection, site not specified.” In this 
case, they were assigned to either the cystitis or pyelonephritis 
group based on the study team’s interpretation of the patient’s 
signs and symptoms. Errors in this designation by the study 
team would have affected the assessment of the appropriateness 
of antibiotics received. In an effort to check cohort assignment, 
we performed statistical analysis and found no significant 
difference in the appropriateness of discharge antibiotic type 
between patients whom the study team assigned to cystitis vs 
pyelonephritis and patients who had an ED diagnosis code for 
cystitis or pyelonephritis specifically (p > 0.05). Additionally, we 
did not assess why providers chose antibiotics that deviated from 
the recommendations, such as resistance in past urine cultures or 
lack of awareness of the guidelines. Furthermore, urine culture 
was used to assess presence of true infection; however, not all 
patients received cultures, which could affect our conclusions 
about the prevalence of true UTI in our study. 
CONCLUSION
This study reveals gaps in the management of children and 
adults with urinary tract infections, including administration 
of antibiotics in the absence of true infection and inappropriate 
choice of discharge antibiotic type, dose, or duration. These 
shortcomings occurred across all three provider types studied and 
represent areas for further education and quality improvement to 
promote antimicrobial stewardship.
Age group Children, n (%) Adult, n (%)
Diagnosis Cystitis Pyelonephritis Cystitis Pyelonephritis
Total 60 (14%) 47 (11%) 198 (47%) 116 (28%)
Appropriate discharge antibiotic type 
  + Appropriate dosea
  + Appropriate dose and durationb
53/60 (88%)
48/60 (80%)
41/60 (68%)
38/47 (81%)
36/47 (77%)
22/47 (47%)
135/198 (68%)
128/198 (65%)
68/198 (34%)
53/116 (46%)
49/116 (42%)
26/116 (22%)
a Appropriate antibiotic type and correct dose.  
b Appropriate antibiotic type and correct dose and duration.
Table 2. Appropriateness of antibiotic prescriptions for urinary tract infection.
Doxycycline 
(n = 2, 13%)
Fluroquinolones
(n = 5, 31%)
Nitrofurantoin for 
pyelonephritis (n = 1, 6%)
Amoxicillin 
(n = 8, 50%)
Figure 2. Inappropriate antibiotic types prescribed for children with 
urinary tract infections.
Beta-lactams 
(n = 92, 73%)
Other (n = 5, 4%)Fluroquinolones for 
cystitis (n = 7, 6%)
Nitrofurantoin for 
pyelonephritis 
(n = 15, 12%)
Amoxicillin (n = 7, 6%)
Figure 3. Inappropriate antibiotic types prescribed for adult women 
with urinary tract infections.
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